Our Medicines Our Stories Global Patient Week

Skip to main content

Contact Us Careers

Americas

Argentina

Brazil

Canada

Chile

Colombia

Mexico

Peru

United States

Asia Pacific

Australia

China

Simplified Chinese

India

Japan

Korea

Korean

New Zealand

Singapore

Taiwan

Traditional Chinese

Thailand

Europe

Austria

German

Belgium

English Dutch French

Czech Republic

Czech

Denmark

Danish

Finland

France

French

Germany

German

Greece

Greek

Hungary

Ireland

Italy

Luxembourg

Netherlands

Norway

Poland

Polish

Portugal

Romania

Spain

Sweden

Switzerland

United Kingdom

Middle East

Israel

Hebrew

Saudi Arabia

Turkey

United Arab Emirates

Other

Other Markets

Distributor Markets

bmsUScqPageLucene

Medicines > Careers > Press Releases > Medical Information >

Our Medicines

Patients & Caregivers

Our medicines

Get help paying for your medicine

Patient resources

Risk Evaluation and Mitigation Strategies (REMS)

QUICK LINKS

Immunology Patient Resources >

Our position on generic drugs >

Our position on drug pricing >

Healthcare Providers

Learn About Pre-Approval Access

Learn About Post Study Drug Access

340B Distribution Practice Fact Sheet

QUICK LINKS

U.S. medical information >

Clinical trials >

Pre-Approval Access Request System >

Post Study Drug Access Request System >

Researchers

Areas of Focus

In the pipeline

Our R&D team

Our efforts in STEM

Clinical Trials & Research

Independent Research

The Thomas O. Daniel Research Incubator and Collaboration Center

QUICK LINKS

Perspectives from our Head of Research >

Research Publications >

Disclosure Commitment >

Investigator Sponsored Research Portal >

Areas of Interest & Competitive Research Grants >

Compound & Technology Requests >

Data Sharing Request Process >

Investors

Stock information

Financial reporting

Analyst coverage

Events and presentations

Shareholder Services

Acquisition-related information for Celgene shareholders

Investor contacts

QUICK LINKS

Annual Report 2022 >

Dividend history >

Stock split history >

Investment return calculator >

SEC filings >

Quarterly Results >

Product Sales summary >

Annual Reports >

Annual Meeting of Shareholders >

Business Development

Our Partnerships

Why Partner With Us

Areas of Interest

Business Development Leadership Team

Begin a Discussion

Global Alliances leadership team

Early Innovation at BMS

QUICK LINKS

Download Business Development Brochure >

"Golden Ticket" Contests >

News

Press Releases

Our Stories

Medical Meetings

Media Library

Media Contacts

QUICK LINKS

Scientific Media Resources >

Disease State Infographics >

Corporate Publications >

About Us

Our company

Leadership

Global Inclusion & Diversity

Responsibility

Sustainability

Contact Us

QUICK LINKS

Global Patient Week >

Survivorship Today >

History Timeline >

Worldwide Locations >

The Bristol Myers Squibb Foundation >

People & Business Resource Groups >

Our Commitment to Global Inclusion & Diversity >

Position on Key Issues >

News / Media Library / Scientific Media Resources

Lymphocyte-Activation Gene 3 (LAG-3)

Download Lymphocyte-Activation Gene 3 (LAG-3) Fact Sheet >

Quick Links

Home
Patients & Caregivers
Healthcare Providers
Researchers
Investors
Careers
News

Resources

Our Medicines
Our Stories
About Us
UK-CA Slavery and Human Trafficking Statement (PDF)

Follow Us

Legal Notice
Privacy Notice
Trademarks
Forward-Looking Statement
Worldwide Locations
Contact Us

May 25, 2021

© 2023 Bristol-Myers Squibb Company